New Approach For Simvastatin As An Antibacterial: Synergistic Effect With Bio-Synthesized Silver Nanoparticles Against Multidrug-Resistant Bacteria

EP Figueiredo,1 JM Ribeiro,1 EK Nishio,1 S Scandorieiro,1 AF Costa,2 VF Cardozo,1 AG Oliveira,1 N Durán,2–4 LA Panagio,1 RKT Kobayashi,1 G Nakazato1 1Department of Microbiology, Center of Biological Sciences, Universidade Estadual de Londrina, Londrina, Paraná, Brazil...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Figueiredo EP, Ribeiro JM, Nishio EK, Scandorieiro S, Costa AF, Cardozo VF, Oliveira AG, Durán N, Panagio LA, Kobayashi RKT, Nakazato G
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2019
Materias:
Acceso en línea:https://doaj.org/article/ad6a3436151b415ba5fce21162e3aabb
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:ad6a3436151b415ba5fce21162e3aabb
record_format dspace
spelling oai:doaj.org-article:ad6a3436151b415ba5fce21162e3aabb2021-12-02T00:05:28ZNew Approach For Simvastatin As An Antibacterial: Synergistic Effect With Bio-Synthesized Silver Nanoparticles Against Multidrug-Resistant Bacteria1178-2013https://doaj.org/article/ad6a3436151b415ba5fce21162e3aabb2019-10-01T00:00:00Zhttps://www.dovepress.com/new-approach-for-simvastatin-as-an-antibacterial-synergistic-effect-wi-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013EP Figueiredo,1 JM Ribeiro,1 EK Nishio,1 S Scandorieiro,1 AF Costa,2 VF Cardozo,1 AG Oliveira,1 N Durán,2–4 LA Panagio,1 RKT Kobayashi,1 G Nakazato1 1Department of Microbiology, Center of Biological Sciences, Universidade Estadual de Londrina, Londrina, Paraná, Brazil; 2NanoBioss, Institute of Chemistry, Universidade Estadual de Campinas, Campinas, São Paulo, Brazil; 3Institute of Chemistry, Universidade Estadual de Campinas, Campinas, São Paulo, Brazil; 4LNNano (National Laboratory of Nanotecnology), CNPEM, Campinas, São Paulo, BrazilCorrespondence: G NakazatoDepartment of Microbiology, Center of Biological Sciences, Universidade Estadual de Londrina, Campus Universitário, CEP, Londrina 86055-990, Paraná, BrazilTel +55 43 3371 4396Fax +55 43 3371 4788Email gersonakazato@yahoo.com.brBackground: Multidrug-resistant bacteria such as extended-spectrum beta-lactamase (ESBL), Enterobacteriaceae, and methicillin-resistant Staphylococcus aureus (MRSA) pose a challenge to the human health care system. MRSA is among the major causes of hospital-acquired and community infections.Methods: Therefore, in the present study, we evaluated the antibacterial activity of silver nanoparticles synthesized by Fusarium oxysporum (AgNPbio) in combination with simvastatin against reference and multidrug-resistant bacterial strains.Results: Simvastatin showed a minimal inhibitory concentration (MIC) ranging from 0.062 to 0.25 mg mL−1 against MRSA. AgNPbio with a size of 77.68± 33.95 nm and zeta potential −34.6 ± 12.7 mV showed an MIC of 0.212 mg mL−1 against S. aureus including MRSA strains. The checkerboard assay and time-kill curves exhibited a synergistic effect of the simvastatin-AgNPbio combination on antibacterial activity against MRSA strains. The combination of simvastatin and AgNPbio demonstrated antibacterial activity against Escherichia coli producing ESBL. Scanning electron microscopy showed the formation of cell surface protrusions after treatment with AgNPbio and the formation of a large amorphous mass after treatment with simvastatin, both in MRSA.Conclusion: Our results indicate that the combination of AgNPbio and simvastatin could be a great future alternative in the control of bacterial infections, where, when combined with simvastatin, smaller doses of AgNPbio are required, with the same antibacterial activity.Keywords: antibacterial, metallic nanoparticles, multidrug-resistant bacterial, statins, synergismFigueiredo EPRibeiro JMNishio EKScandorieiro SCosta AFCardozo VFOliveira AGDurán NPanagio LAKobayashi RKTNakazato GDove Medical PressarticleAntibacterialmetallic nanoparticlesmultidrug-resistant bacterialstatinssynergismMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 14, Pp 7975-7985 (2019)
institution DOAJ
collection DOAJ
language EN
topic Antibacterial
metallic nanoparticles
multidrug-resistant bacterial
statins
synergism
Medicine (General)
R5-920
spellingShingle Antibacterial
metallic nanoparticles
multidrug-resistant bacterial
statins
synergism
Medicine (General)
R5-920
Figueiredo EP
Ribeiro JM
Nishio EK
Scandorieiro S
Costa AF
Cardozo VF
Oliveira AG
Durán N
Panagio LA
Kobayashi RKT
Nakazato G
New Approach For Simvastatin As An Antibacterial: Synergistic Effect With Bio-Synthesized Silver Nanoparticles Against Multidrug-Resistant Bacteria
description EP Figueiredo,1 JM Ribeiro,1 EK Nishio,1 S Scandorieiro,1 AF Costa,2 VF Cardozo,1 AG Oliveira,1 N Durán,2–4 LA Panagio,1 RKT Kobayashi,1 G Nakazato1 1Department of Microbiology, Center of Biological Sciences, Universidade Estadual de Londrina, Londrina, Paraná, Brazil; 2NanoBioss, Institute of Chemistry, Universidade Estadual de Campinas, Campinas, São Paulo, Brazil; 3Institute of Chemistry, Universidade Estadual de Campinas, Campinas, São Paulo, Brazil; 4LNNano (National Laboratory of Nanotecnology), CNPEM, Campinas, São Paulo, BrazilCorrespondence: G NakazatoDepartment of Microbiology, Center of Biological Sciences, Universidade Estadual de Londrina, Campus Universitário, CEP, Londrina 86055-990, Paraná, BrazilTel +55 43 3371 4396Fax +55 43 3371 4788Email gersonakazato@yahoo.com.brBackground: Multidrug-resistant bacteria such as extended-spectrum beta-lactamase (ESBL), Enterobacteriaceae, and methicillin-resistant Staphylococcus aureus (MRSA) pose a challenge to the human health care system. MRSA is among the major causes of hospital-acquired and community infections.Methods: Therefore, in the present study, we evaluated the antibacterial activity of silver nanoparticles synthesized by Fusarium oxysporum (AgNPbio) in combination with simvastatin against reference and multidrug-resistant bacterial strains.Results: Simvastatin showed a minimal inhibitory concentration (MIC) ranging from 0.062 to 0.25 mg mL−1 against MRSA. AgNPbio with a size of 77.68± 33.95 nm and zeta potential −34.6 ± 12.7 mV showed an MIC of 0.212 mg mL−1 against S. aureus including MRSA strains. The checkerboard assay and time-kill curves exhibited a synergistic effect of the simvastatin-AgNPbio combination on antibacterial activity against MRSA strains. The combination of simvastatin and AgNPbio demonstrated antibacterial activity against Escherichia coli producing ESBL. Scanning electron microscopy showed the formation of cell surface protrusions after treatment with AgNPbio and the formation of a large amorphous mass after treatment with simvastatin, both in MRSA.Conclusion: Our results indicate that the combination of AgNPbio and simvastatin could be a great future alternative in the control of bacterial infections, where, when combined with simvastatin, smaller doses of AgNPbio are required, with the same antibacterial activity.Keywords: antibacterial, metallic nanoparticles, multidrug-resistant bacterial, statins, synergism
format article
author Figueiredo EP
Ribeiro JM
Nishio EK
Scandorieiro S
Costa AF
Cardozo VF
Oliveira AG
Durán N
Panagio LA
Kobayashi RKT
Nakazato G
author_facet Figueiredo EP
Ribeiro JM
Nishio EK
Scandorieiro S
Costa AF
Cardozo VF
Oliveira AG
Durán N
Panagio LA
Kobayashi RKT
Nakazato G
author_sort Figueiredo EP
title New Approach For Simvastatin As An Antibacterial: Synergistic Effect With Bio-Synthesized Silver Nanoparticles Against Multidrug-Resistant Bacteria
title_short New Approach For Simvastatin As An Antibacterial: Synergistic Effect With Bio-Synthesized Silver Nanoparticles Against Multidrug-Resistant Bacteria
title_full New Approach For Simvastatin As An Antibacterial: Synergistic Effect With Bio-Synthesized Silver Nanoparticles Against Multidrug-Resistant Bacteria
title_fullStr New Approach For Simvastatin As An Antibacterial: Synergistic Effect With Bio-Synthesized Silver Nanoparticles Against Multidrug-Resistant Bacteria
title_full_unstemmed New Approach For Simvastatin As An Antibacterial: Synergistic Effect With Bio-Synthesized Silver Nanoparticles Against Multidrug-Resistant Bacteria
title_sort new approach for simvastatin as an antibacterial: synergistic effect with bio-synthesized silver nanoparticles against multidrug-resistant bacteria
publisher Dove Medical Press
publishDate 2019
url https://doaj.org/article/ad6a3436151b415ba5fce21162e3aabb
work_keys_str_mv AT figueiredoep newapproachforsimvastatinasanantibacterialsynergisticeffectwithbiosynthesizedsilvernanoparticlesagainstmultidrugresistantbacteria
AT ribeirojm newapproachforsimvastatinasanantibacterialsynergisticeffectwithbiosynthesizedsilvernanoparticlesagainstmultidrugresistantbacteria
AT nishioek newapproachforsimvastatinasanantibacterialsynergisticeffectwithbiosynthesizedsilvernanoparticlesagainstmultidrugresistantbacteria
AT scandorieiros newapproachforsimvastatinasanantibacterialsynergisticeffectwithbiosynthesizedsilvernanoparticlesagainstmultidrugresistantbacteria
AT costaaf newapproachforsimvastatinasanantibacterialsynergisticeffectwithbiosynthesizedsilvernanoparticlesagainstmultidrugresistantbacteria
AT cardozovf newapproachforsimvastatinasanantibacterialsynergisticeffectwithbiosynthesizedsilvernanoparticlesagainstmultidrugresistantbacteria
AT oliveiraag newapproachforsimvastatinasanantibacterialsynergisticeffectwithbiosynthesizedsilvernanoparticlesagainstmultidrugresistantbacteria
AT durann newapproachforsimvastatinasanantibacterialsynergisticeffectwithbiosynthesizedsilvernanoparticlesagainstmultidrugresistantbacteria
AT panagiola newapproachforsimvastatinasanantibacterialsynergisticeffectwithbiosynthesizedsilvernanoparticlesagainstmultidrugresistantbacteria
AT kobayashirkt newapproachforsimvastatinasanantibacterialsynergisticeffectwithbiosynthesizedsilvernanoparticlesagainstmultidrugresistantbacteria
AT nakazatog newapproachforsimvastatinasanantibacterialsynergisticeffectwithbiosynthesizedsilvernanoparticlesagainstmultidrugresistantbacteria
_version_ 1718403948012896256